| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 97 |
| 1 | AZACITIDINE | 49 |
| 2 | RUXOLITINIB | 29 |
| 3 | DEFERASIROX | 27 |
| 4 | FOLIC ACID | 23 |
| 5 | FUROSEMIDE | 23 |
| 6 | VENETOCLAX | 23 |
| 7 | AZACITIDINE FOR | 21 |
| 8 | CYCLOPHOSPHAMIDE | 21 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARBAMIDE PEROXIDE 6.5% | 1 | 0.0222 |
| 1 | OBECABTAGENE AUTOLEUCEL | 1 | 0.0141 |
| 2 | CEDAZURIDINE AND DECITABINE | 5 | 0.0051 |
| 3 | OLUTASIDENIB | 1 | 0.0035 |
| 4 | ECULIZUMAB | 97 | 0.0018 |
| 5 | DANAZOL | 5 | 0.0018 |
| 6 | VARDENAFIL | 1 | 0.0017 |
| 7 | AZACITIDINE | 49 | 0.0016 |
| 8 | LUSPATERCEPT | 4 | 0.0015 |
| 9 | PURIXAN | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 101 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 63 |
| 2 | Corticosteroid [EPC] | 41 |
| 3 | Kinase Inhibitor [EPC] | 33 |
| 4 | Janus Kinase Inhibitor [EPC] | 29 |
| 5 | Iron Chelator [EPC] | 28 |
| 6 | Alkylating Drug [EPC] | 27 |
| 7 | Vitamin C [EPC] | 26 |
| 8 | Loop Diuretic [EPC] | 25 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement Inhibitor [EPC] | 101 | 0.0018 |
| 1 | Erythroid Maturation Agent [EPC] | 4 | 0.0015 |
| 2 | Iron Chelator [EPC] | 28 | 0.0010 |
| 3 | Interferon gamma [EPC] | 1 | 0.0007 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 4 | 0.0004 |
| 6 | BCL-2 Inhibitor [EPC] | 23 | 0.0004 |
| 7 | Erythropoiesis-stimulating Agent [EPC] | 19 | 0.0004 |
| 8 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |